Trinova Capital Announce Addition of Samuel Shakeson to Equity Research TeamTrinova Capital, an independent equity research and alternative asset management firm, has today announced that Samuel Shakeson has joined the firm as a speciality pharmaceuticals equity research analyst.
“Samuel has been in the biopharmaceutical industry for over 20 years, primarily as a clinical pharmacologist,” said Edward Barton, Senior Portfolio Manager at Trinova. “He brings a wealth of experience to Trinova Capital, having worked in the wealth management industry in the United Kingdom and USA. He is extraordinarily positioned to bring our institutional brokerage clients insight into a highly specialised sector. We all look forward to working with Sam and listening to the fresh ideas he has for the future of Trinova Capital.”
Mr Shakeson’s role will primarily be back-of-house as he will be focused on discovering new and emerging trends in the biopharmaceutical sector and he will be joining an existing team of 12.
Mr Shakeson said of his appointment “Trinova Capital has a great presence in the Asia-Pacific region, so when the opportunity arose to work here I grasped it with both hands. I’m really excited about meeting my new team-mates and colleagues. Together we can continue to springboard Trinova Capital’s growth both in the Asia-Pacific region and worldwide for years to come.”
Mr Shakeson’s role at Trinova Capital commences Monday 4th April 2016 at the firm’s Tokyo-based headquarters.
Trinova Capital is a leading independent equity research firm based in Tokyo, Japan. Please visit www.trinovacapital.com. Alternatively, you can email firstname.lastname@example.org or call +813 4588 8434.
Trinova Capital is an independent equity research firm based in Tokyo who provide market reports and financial advice to their private and institutional client globally.
Otemachi Financial City, North Tower, 1-9-5 Otemachi, Chiyoda-ku, Tokyo, 100-0004, Japan
Telephone - 0081345888434
Email - email@example.com
Media Contact - Alexander Kidd (firstname.lastname@example.org)
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Trinova Capital Announce Addition of Samuel Shakeson to Equity Research Team here
News-ID: 329195 • Views: …
More Releases from Trinova Capital
Trinova Capital’s Edward Barton Takes Control of Firm’s European Client Driv …
Edward Barton of Trinova Capital has been appointed to lead governance of the equity research firm’s European Client Drive. Mr Barton has been a Senior Portfolio Manager with Trinova since the inception of the firm’s private client division and has spearheaded every European Client Drive for the past few years. “Whilst I have been at the helm of every private client drive for Trinova Capital, this year is much more exceptional,
Trinova Capital on track for record-breaking Q1 of 2016.
Trinova Capital, the equity research firm in Tokyo, has turned in an impressive Q1 performance with a monumental 74% year-on-year growth in revenue forecast compared with the same period in 2015. The impressive growth was fuelled by many discerning aspects, primarily the induction of new clients and over-performing portfolios, as well as a restructuring of the firm to reduce overheads. Alexander Steiner spoke on the projections, “If our estimations turn out to
Trinova Capital Announce New Institutional Business Development Manager
Trinova Capital today announced the appointment of Kieran Bessington as Institutional Business Development Manager. He will be responsible for building new client relationships and driving Trinova’s presence in the corporate and local authority pensions market. Mr Bessington joins an existing team of 14. Kieran Bessington’s career spans over two decades, with his most recent role focusing on institutional sales and consultant relations. Kieran has also held roles in fixed income and